Washed human blood platelets contain a clottable protein that is similar to, if not identical with, plasma fibrinogen (1-4). After incubation with trypsin under appropriate conditions, platelets remain morphologically intact but no longer contain clottable protein (5). Trypsinized platelets, unlike normal platelets, are not aggregated by fresh serum or by a solution of thrombin and calcium chloride. When resuspended in plateletfree plasma or in a buffered solution of fibrinogen containing glucose, trypsinized platelets produce retraction of clots formed by thrombin; during the formation of the clot and its subsequent retraction, trypsinized platelets aggregate and undergo the usual changes of viscous metamorphosis (5). These observations suggest that fibrinogen on the surface of platelets is involved in the reaction of platelets to thrombin. This reaction does not consist simply of the coagulation of fibrinogen with entrapment of platelets in the fibrin mesh. Under usual conditions divalent cations are required for thrombin-induced platelet aggregation but not for clotting of fibrinogen (5, 6). Electron photomicrographs of platelet aggregates show no striated fibrin strands between adherent
Washed human blood platelets contain a clottable protein that is similar to, if not identical with, plasma fibrinogen (1) (2) (3) (4) . After incubation with trypsin under appropriate conditions, platelets remain morphologically intact but no longer contain clottable protein (5) . Trypsinized platelets, unlike normal platelets, are not aggregated by fresh serum or by a solution of thrombin and calcium chloride. When resuspended in plateletfree plasma or in a buffered solution of fibrinogen containing glucose, trypsinized platelets produce retraction of clots formed by thrombin; during the formation of the clot and its subsequent retraction, trypsinized platelets aggregate and undergo the usual changes of viscous metamorphosis (5) . These observations suggest that fibrinogen on the surface of platelets is involved in the reaction of platelets to thrombin. This reaction does not consist simply of the coagulation of fibrinogen with entrapment of platelets in the fibrin mesh. Under usual conditions divalent cations are required for thrombin-induced platelet aggregation but not for clotting of fibrinogen (5, 6) . Electron photomicrographs of platelet aggregates show no striated fibrin strands between adherent platelets (7) . Accordingly, additional studies were undertaken using enzymes known to alter plasma fibrinogen to define more precisely the role of platelet fibrinogen in the reaction of platelets to thrombin.
Methods
Platelet-rich plasma was obtained from human donors by plasmapheresis (8) with plastic equipment' or by centrifugation of venous blood at 50 g for 30 minutes at room temperature. Glassware with which platelets had contact was coated with silicone.2 One-tenth volume of a 1.5% solution of the disodium salt of EDTA was used as anticoagulant. Platelet-free plasma was obtained by centrifugation at 22,000 g for 10 minutes at 40 C. Platelets were sedimented from 20 to 40 ml of platelet-rich plasma by centrifugation at 1,900 g for 10 minutes at room temperature. The sedimented platelets were resuspended in 5 ml of EDTA Tris-buffered saline (equal volumes 0.3 M Tris solution and 0.9% sodium chloride, pH adjusted to 7.5 with 2 N hydrochloric acid and containing EDTA, 0.0013 M). The platelets were washed twice by centrifugation at 4,700 g for 5 minutes at 40 C and resuspension in 5 ml of the EDTA Tris-buffered saline. They were then resuspended in EDTA Tris-buffered saline, and various amounts of one of the following proteolytic enzymes were added: bovine thrombin,s trypsin,4 plasminogen prepared by the modified Kline method (9) from human plasma Fraction III 5 dase.10 The platelets were incubated with the enzyme for 10 minutes at 370 C in a final volume of 5 ml. During incubation with thrombin an EDTA concentration of 0.008 M was used to inhibit aggregation. In some experiments inhibitors were added following the incubation to assure cessation of enzyme activity. e-Aminocaproic acid (EACA) 11 or a bovine lung inhibitor 12 was used to inhibit plasmin, soy bean trypsin inhibitor 13 to inhibit trypsin, and heparin14 to inhibit thrombin. The platelets then were immediately centrifuged in the cold and washed once with and resuspended in 5 ml EDTA Trisbuffered saline. Samples of these suspensions were used for the following studies.
Aggregation. Five-tenths ml was centrifuged at 1,800 g for 5 minutes, and the platelets were suspended in 0.2 ml Tris-buffered saline without EDTA in siliconized tubes to which was added 0.05 ml of a solution of thrombin, 100 U per ml in 0.025 M CaCl2. The tubes were gently agitated and observed for gross and microscopic aggregation. Aggregation was graded as follows: 0, no aggregation; 1 +, few small clumps; 2 +, numerous small clumps; 3 +, many large clumps; 4 +, very large clumps with few free platelets.
Clot retraction. Five-tenths ml was centrifuged at 1,800 g for 5 minutes, and the platelets were resuspended in 0.3 ml platelet-free plasma in siliconized tubes to which was added 0.1 ml of a solution of thrombin, 100 U per ml in 0.025 M CaCl2. The tubes were inverted once and incubated at 370 C. Clot retraction was graded at 2 hours and again at 24 hours: 0, no retraction; 1 +, separation of clot from wall of tube; 2 +, clot retracted to half the volume in the tube; 3 +, clot retracted to onequarter of the volume in the tube; and 4+, small retracted clot similar to control. In experiments with plasmin-treated platelets, 0.025 ml of EACA was added to the plasma before the addition of thrombin and calcium.
Clottable protein. Three ml was centrifuged at 22,000 g for 10 minutes, and the platelets were frozen and thawed five times in 0.2 ml of a 0.9% solution of sodium chloride with alcohol-dry ice. The suspension was centrifuged at 22,000 g for 10 minutes and the supernatant tested for clottable protein by the addition of 0.1 ml of a solution of glycerol and was concentrated to the original volume by negative pressure.
8 a-Chymotrypsin 3 X crystallized, Worthington Biochemical Corp., Freehold, N. J.thrombin, 100 U per ml in 0.025 M CaCl2. The tubes were observed constantly for 6 minutes, then periodically for 2 hours and again at 24 hours.
Serotonin. One ml was centrifuged at 22,000 g for 10 minutes, and the platelets were frozen and thawed five times in 3.0 ml of 0.02 N hydrochloric acid. The serotonin concentration of 2.0 ml of the suspension was determined by a modified spectrophotofluorometric method (10) and was related to the protein concentration, which was measured on 0.5 ml by the method of Sutherland, Cori, Haynes, and Olsen (11) . Serotonin release was expressed as percentage of decrease in the treated platelets as compared to controls.
ATP. In six experiments 3.0-ml portions of suspensions of platelets that had been incubated with thrombin, trypsin, or plasmin were centrifuged at 22,000 g for 10 minutes and the platelets lysed in 2.0 ml of cold 3% trichloroacetic acid. The sediment was removed by centrifugation at 22,000 g for 10 minutes and the supernatant chromatographed on a Dowex 1 anion exchange column that was 4 cm long and 1.0 cm in diameter. Two ml of distilled water was added to the column after addition of the 2.0 ml of supernatant. The acid-soluble nucleotides were isolated by intermittent gradient elution with 4.0-ml volumes of formic acid and mixtures of formic acid and ammonium formate as described by Siekevitz and Potter (12) The activity of the streptokinase-activated plasminogen was measured by the method of Norman (13) . The proteolytic (caseinolytic) activities of some of the enzymes were compared using a pH stat (14) .
Results
Washed human blood platelets incubated with various concentrations of thrombin in the presence of EDTA did not aggregate or lyse during the incubation (Table I) . Serotonin was released from the platelets by concentrations of thrombin that did not completely inactivate clottable protein. Higher concentrations of thrombin inactivated the clottable protein, and such platelets no longer aggregated when subsequently incubated with thrombin and calcium. Although slight morphologic variations were seen following incubation with thrombin, the platelets remained intact and retained the ability to produce retraction of clots when suspended in platelet-free plasma to which thrombin and calcium were then added.
The addition of heparin following incubation with thrombin did not alter the results. However, the addition of heparin before incubation with thrombin completely inhibited the effects of thrombin.
Similar effects were found when washed platelets were incubated with trypsin (Table II) * Twice washed platelets were incubated for 10 minutes at 37°C in Tris-buffered saline containing EDTA (0.008 M) and thrombin in the concentrations indicated. Following incubation the platelets were washed twice in Tris-buffered saline containing EDTA (0.0013 M) and the studies performed. The results were unchanged when heparin (200 U per ml) was added after incubation to block thrombin action. The Table is (Table IV) . In studies with plasmin it was necessary to add EACA or * Twice washed platelets were incubated for 10 minutes at 370 C in 5.0 ml of buffer or in 4.0 ml of buffer containing 1.0 ml of concentrated plasmin. Bovine plasmin inhibitor (Bayer 3380 RK) was added, and the platelets were washed twice in EDTA Tris-buffered saline. Thrombin and calcium were added to one portion of each of the control and plasmin-treated platelets. Control platelets aggregated, but plasmin-treated platelets did not. The platelets were sedimented, and serotonin and ATP were determined and related to platelet protein.
lysates of control platelets, and they' dissolved clots formed from lysates of control platelets (Table V) . These results demonstrate that fibrinolytic activity was present in lysates of washed plasmin-treated platelets and furthermore indicate that although the clottable protein of the intact platelet was not completely inactivated by plasmin, this protein when freed from the platelet by freezing and thawing was inactivated by plasmin. Little or no serotonin was released from the platelets by incubation with either of the plasmin preparations except when the platelets were suspended directly in the spontaneously activated plasmin. Plasmin-treated platelets that contained clottable protein were not aggregated by addition of thrombin and calcium (Table IV) , but did release serotonin and ATP (Table VI) . The ability of the platelets to support clot retraction was not altered even after incubation in the undiluted plasmin (Table IV) . Incubation of platelets with streptokinase alone produced no detectable alterations.
Incubation of the platelets with a-chymotrypsin produced effects similar to the effects of plasmin (Table VII) . Serotonin was released only after incubation with large amounts (1 to 5 mg per ml), and the clottable protein was not inactivated by concentrations that interfered with platelet aggregation. After incubation with concentrations of a-chymotrypsin of 5 mg per ml, the clottable protein could not be demonstrated in the platelet lysate, but the platelets nevertheless functioned in clot retraction.
Carboxypeptidase, an enzyme that does not interfere with the clotting of plasma fibrinogen by thrombin (15) , had no detectable effect on platelets in concentrations up to 5 mg per ml.
The proteolytic activities of some of the enzymes employed were compared by a caseinolytic assay. With 4%o casein as substrate in a pH stat, approximately equivalent rates of hydrolysis were found for 25 Jug per ml trypsin, 10 mg per ml streptokinase-activated plasminogen, and 500
,pg per ml a-chymotrypsin. Thrombin had very little activity by this assay (Figure 1 ). ATP release from concentrated washed platelets was measured with comparable proteolytic concentrations of plasmin and trypsin and arbitrarily 25 U per ml of thrombin. Plasmin released little ATP over a 30-minute incubation, whereas trypsin released substantial amounts. Thrombin released most of the ATP in a very short time (Figure 2 In two experiments each, twice washed platelets were incubated for various times with thrombin, 25 U per ml; trypsin, 25 ,ug per ml; or spontaneously activated plasmin, 0.5 ml in 4.5 ml buffer. The reactions were stopped by adding the appropriate inhibitor; then the platelets were washed twice in 5 ml EDTA Tris-buffered saline and divided for protein determination and chromatography of the adenosine nucleotides. The curves shown are an expression of the average ATP lost as compared with controls incubated without enzyme. gated by thrombin. The clottable protein probably was not actually removed from the platelet by these enzymes, but was so altered that it no longer reacted to thrombin. It has been suggested that fibrinogen remains within enzymetreated platelets, since fluorescent antifibrinogen antibodies have been reported to react with trypsinized platelets and megakaryocytes (16) . However, the lysed products of fibrinogen remain antigenically active (17) (18) (19) , and it is possible that antigenic portions of fibrinogen which are no longer clottable by thrombin remain associated with enzyme-treated platelets. Lysis of platelets by osmotic gradient releases fibrinogen into the medium, a phenomenon which has been interpreted to imply that fibrinogen is contained within the platelet (20) . However, frozen and thawed lysates of platelets contain cellular debris and lipid particles even after ultracentrifugation (64,-000 g for 30 minutes), suggesting that membrane constituents remain in the supernatant fluid (21) .
Relatively small concentrations of trypsin or thrombin were reported to release fibrinogen from high concentrations of porcine platelets when incubated at 250 C, and the fibrinogen was observed to clot outside the platelet, suggesting that thrombin acts on a hitherto unknown protein on the platelet surface to release fibrinogen, which then clots (22) . Our observations are at variance with these, possibly because of the different conditions of the experiments. The observation that trypsin inactivated the clottable protein suggests that fibrinogen was physically bound on the platelet surface (5) . Trypsin is thought to react first with the same peptide bonds in fibrinogen as thrombin does (14, 15, 23) . Papain, which is known to clot plasma fibrinogen (24) (25) (26) , produced effects on platelets similar to thrombin and trypsin. It seems possible that thrombin, trypsin, and papain alter the platelet membrane by acting in a similar manner on platelet fibrinogen.
Dilutions of plasmin and a-chymotrypsin under the conditions employed did not eliminate clottable protein from platelets, but did inhibit aggregation of platelets by thrombin. Failure of plasmin to inactivate platelet fibrinogen cannot be attributed to lack of potency of the preparations, since rapid fibrinogenolysis occurred in plasmintreated platelets when the platelets were mechanically disrupted. It is possible that some of the platelet fibrinogen is incorporated in the platelet and is structurally protected from the action of plasmin. Furthermore, antiplasmin activity that has been reported to be associated with the platelet (27) may protect platelet fibrinogen from the effects of plasmin in the intact platelet. Fibrin degradation products have been reported to interfere with platelet aggregation, presumably by inhibiting the action of thrombin on fibrinogen (28) . It seems unlikely that this observation would explain the inhibition of thrombin-induced aggregation by plasmin, since plasmin-treated platelets do react to thrombin by release of serotonin and ATP. The products of plasmin-digested fibrinogen have been shown to interfere with polymerization of plasma fibrinogen after thrombin action (29, 30) and with aggregation of platelets by thrombin (31) , and it is conceiv-able that products of plasmin digestion adherent to the surface of the platelet might interfere with polymerization of platelet fibrinogen. Furthermore, plasmin itself digests fibrinogen into fragments that are not polymerized by thrombin (32) . Thus, plasmin and a-chymotrypsin possibly interfere with aggregation of platelets by thrombin by lysing bonds in platelet fibrinogen that are necessary for polymerization. However, other possibilities must be considered. These enzymes may inhibit aggregation of platelets by thrombin by effects on constituents of the platelet surface other than fibrinogen. Platelets from some patients with congenital afibrinogenemia lacked fibrinogen by immunochemical techniques, but were aggregated by thrombin and agglutinated by antifibrinogen antibody (33) . Such platelets may contain either trace amounts of normal fibrinogen or another protein, possibly related to fibrinogen, which reacts with thrombin in the production of platelet aggregation.
It has been suggested that thrombin-induced aggregation of platelets is mediated through ADP (34) . Plasmin-treated platelets contained almost normal amounts of ATP, which was released by addition of thrombin, yet these platelets did not aggregate. This observation does not eliminate the possibility that ADP may be involved in thrombin-induced aggregation, since plasmin treatment may have altered the platelet surface so that ADP had no effect.
Thrombin, trypsin, and papain, which removed clottable protein from platelets, also caused rapid release of serotonin from the platelets. Serotonin release, however, was regularly observed with concentrations of the enzymes that were too low to inactivate all of the clottable protein. It is possible that when platelet fibrinogen is enzymatically split, the platelet membrane may be so altered that intracellular constituents are allowed to escape even before all of the clottable protein has been inactivated.
Plasmin and a-chymotrypsin in concentrations that interfered with aggregation of platelets by thrombin did not remove clottable protein or release serotonin from the platelets. Platelets treated with plasmin and a-chymotrypsin did react to the subsequent addition of thrombin by release of serotonin. Fragments of plasmindigested fibrinogen that are unable to polymerize are nonetheless capable of being split by thrombin (32) . Thus, thrombin may produce release of serotonin from plasmin-treated platelets by further splitting of plasmin-digested platelet fibrinogen. Alternatively release of serotonin from platelets by thrombin may not be due to an effect on platelet fibrinogen but may involve another mechanism. Platelets from certain patients with thrombocytopathic purpura have been found to be deficient in platelet fibrinogen, and platelets from these patients were not aggregated by thrombin, but did release serotonin and ATP following exposure to thrombin (35, 36) .
Aggregation of platelets by thrombin appears to depend on a multiphase reaction involving platelet fibrinogen possibly involving polymerization of the fibrinogen. Release of serotonin and adenosine nucleotides by thrombin may depend only on proteolysis of platelet fibrinogen, but other mechanisms are possible. Summary Thrombin, trypsin, and papain inactivated the clottable protein of human blood platelets and released serotonin and ATP from the platelets. Platelets that did not contain clottable protein after treatment with these enzymes did not aggregate when subsequently incubated with thrombin and calcium, but retained their ability to support clot retraction when suspended in a medium containing fibrinogen.
Plasmin and a-chymotrypsin in concentrations equivalent to trypsin in proteolytic activity did not inactivate the clottable protein or release significant amounts of serotonin or ATP from intact platelets although they rendered the clottable protein incoagulable in platelet lysates. Platelets treated with plasmin and a-chymotrypsin in these concentrations did not aggregate but did release serotonin and ATP when subsequently incubated with thrombin and calcium.
The results are compatible with the hypothesis that platelet fibrinogen is a functional part of the structure of normal platelets.
